Results 201 to 210 of about 124,801 (264)

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Phase-Resolved Two-Dimensional Infrared Spectroscopy of Solution-Phase Vibrational Polaritons on Gold Antenna Meta-Surfaces. [PDF]

J Phys Chem Lett
Sufrin S, Cohn B, Chuntonov L.
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Engineered fano resonances in a compact Si₃N₄ photonic crystal nanobeam-microring platform for multi-cladding environments. [PDF]

Sci Rep
Mendoza-Castro JH, Vorobev AS, Iadanza S, Lendl B, Magno G, O'Faolain L, Grande M.   +6 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Understanding SERS Spectral Shape Variability through Substrate Optics, Molecular Orientation, and Unsupervised Clustering. [PDF]

J Phys Chem C Nanomater Interfaces
Kumar A, Ma F, Chen X, Zhao Y.
europepmc   +1 more source

TiO₂-coated guided-mode resonance gratings for polarization-selective green light filtering. [PDF]

Discov Nano
Aslam K, Mushtaq N, Chai Y, Kang G.
europepmc   +1 more source

Evaluating the Influence of Normalisation Procedures on a Negative Selection Algorithm to Enhance Damage Detection. [PDF]

Sensors (Basel)
Barontini A, Masciotta MG, Ramos LF, Amado-Mendes P, Lourenço PB, Brando G.   +5 more
europepmc   +1 more source

Raman and SERS Spectra of Human Myelin Basic Protein in Cerebrospinal Fluid. [PDF]

Nanomaterials (Basel)
Bravo-Oro A, Ugarte-Anchondo S, Martínez-Ruiz EO, Rodríguez-Aranda MDC, Reyes-Reyes A, García-Mendoza CI, Ortiz-Dosal LC, Rivera-Pérez E, Reyes-Reyes JA, Kolosovas-Machuca ES, Ortiz-Dosal A.   +10 more
europepmc   +1 more source